Product Details

Procrit® Epoetin Alfa 20,000 U / mL Injection Multiple-Dose Vial 1 mL

Manufacturer: Janssen

MFG#: 59676-0320-04

NDC: 59676-0320-04

PID: 350538

This product is not currently available, please contact us for further information.

Product Information

NDC Package Code59676-320-04
Proprietary NameProcrit
Non-Proprietary NameErythropoietin
Package4 VIAL, MULTI-DOSE in 1 CARTON (59676-320-04) > 1 mL in 1 VIAL, MULTI-DOSE (59676-320-00)
Dosage FormINJECTION, SOLUTION
RouteINTRAVENOUS; SUBCUTANEOUS
Active Ingredient Strength20000
Active Ingredient Units[iU]/mL
Substance NameERYTHROPOIETIN

Description

PROCRIT is an erythropoiesis-stimulating agent (ESA) indicated for: 1 Treatment of anemia due to-Chronic Kidney Disease (CKD) in patients on dialysis and not on dialysis (1.1).-Zidovudine in patients with HIV-infection (1.2).-The effects of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy (1.3)., 2 Reduction of allogeneic RBC transfusions in patients undergoing elective, noncardiac, nonvascular surgery (1.4).

Epoetin alfa is a 165-amino acid erythropoiesis-stimulating glycoprotein manufactured by recombinant DNA technology. It has a molecular weight of approximately 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin. PROCRIT (epoetin alfa) injection for intravenous or subcutaneous administration is formulated as a sterile, clear, colorless liquid in vials in multiple formulations. Single-dose vials, formulated with an isotonic sodium chloride/sodium citrate-buffered solution, are supplied in multiple strengths. Each single-dose 1 mL vial contains 2,000, 3,000, 4,000, or 10,000 Units of epoetin alfa, Albumin (Human) (2.5 mg), citric acid (0.06 mg), sodium chloride (5.9 mg), and sodium citrate (5.8 mg) in Water for Injection, USP (pH 6.9 ± 0.3). Single-dose 1 mL vials formulated with an isotonic sodium chloride/sodium phosphate buffer contain 40,000 Units of epoetin alfa albumin (human) (2.5 mg), citric acid (0.0068 mg), sodium chloride (5.8 mg), sodium citrate (0.7 mg), sodium phosphate dibasic anhydrate (1.8 mg), and sodium phosphate monobasic monohydrate (1.2 mg) in Water for Injection, USP (pH 6.9 ± 0.3). Multiple-dose, 2 mL vials contain 10,000 Units epoetin alfa, albumin (human) (2.5 mg), benzyl alcohol (1%), sodium chloride (8.2 mg), citric acid (0.11 mg), and sodium citrate (1.3 mg) per 1 mL Water for Injection, USP (pH 6.1 ± 0.3). Multiple-dose 1 mL vials contain 20,000 Units epoetin alfa, albumin (human) (2.5 mg), benzyl alcohol (1%), sodium chloride (8.2 mg), citric acid (0.11 mg), and sodium citrate (1.3 mg), per 1 mL in Water for Injection, USP (pH 6.1 ± 0.3).

Frequently Asked Questions (FAQs)

The cost of Procrit® Epoetin Alfa 20,000 U / mL Injection Multiple-Dose Vial 1 mL is $available for registerd members only

Procrit® Epoetin Alfa 20,000 U / mL Injection Multiple-Dose Vial 1 mL is manufactured by Janssen.

You can purchase Procrit® Epoetin Alfa 20,000 U / mL Injection Multiple-Dose Vial 1 mL on our website at https://supplies.pipelinemedical.com/product/detail/procrit-erythropoietin-injection-solution-350538